Chawnshang Chang

17PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 18, 2023
The androgen receptor in bladder cancer.

Jinbo Chen, Chi-Ping Huang, Chao Quan

|Nov 18, 2022
Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis.

Changcheng Guo, Yin Sun, Wei Zhai

|Aug 29, 2022
High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals.

Min Tang, Yin Sun, Chi-Ping Huang

|Aug 01, 2022
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling.

Qing Liu, Bosen You, Jialin Meng

|Mar 23, 2022
High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling.

Lei Chen, Yin Sun, Min Tang

|Feb 09, 2022
Targeted activation of androgen receptor signaling in the periosteum improves bone fracture repair.

Kuo-Chung Lan, Kuo-Ting Wei, Pei-Wen Lin

Pageof 3

Frequent Collaborators

7 joint publications

Shuyuan Yeh

3 joint publications

Chi-Ping Huang

3 joint publications

Wanhai Xu

1 joint publications

Xiongbing Zu